Treating Retinal Vein Occlusion (RVO)
We have created two inspiring and imaginative animations for Annexin Pharmaceuticals, which are designed to explain their biological drug candidate ANXV - a recombinant human protein Annexin A5 that can help to treat Retinal Vein Occlusion (RVO). The animations needed to reflect the sophisticated character of the company, with clean and high-end looking animations.
-
SENSU
Strategy. Branding. Content. Design.
For visionary companies at every stage of the innovation chain
We work with companies that change the world.
From hydrogen and life saving medicines to next generation protein sequencers. Our clients make an impact in society - transforming the way we approach the biggest challenges of today and tomorrow. We translate their stories into award winning 3D animations, films, websites, brand identities and more.
🎬 Subscribe to our channel! / sensu_agency
🎬 Subscribe to our playlists
🫀 Life Science: • Life Science
⚙️ High Tech: • High Tech
🎥 Documentary: • Documentary
Read more about this project: sensu.org/cases/annexin-a5
More information about Annexin's biological drug candidate: www.annexinpharma.com/en/the-...
FIND US ONLINE
▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Website: sensu.org
LinkedIn: / sensu-productions
Instagram: / sensu_film
Want to find out what we can do for you? Reach us at info@sensu.org
1 авг 2021
